Background pattern
PEROXIBEN 50 mg/g GEL

PEROXIBEN 50 mg/g GEL

Ask a doctor about a prescription for PEROXIBEN 50 mg/g GEL

5.0(2)
Doctor

Tomasz Grzelewski

Dermatology21 years of experience

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
CameraBook a video appointment
€80
Today11:00
Today11:25
Today11:50
Today12:15
Today12:40
More times
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use PEROXIBEN 50 mg/g GEL

Introduction

Leaflet: information for the user

Peroxiben 50 mg/g gel

Benzoic peroxide

Read this leaflet carefully because it contains important information for you.

This medication can be obtained without a prescription. Nevertheless, to obtain the best results, it should be used properly.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If symptoms worsen or persist after 6 weeks, you should consult a doctor.
  • If you consider that any of the adverse effects you are experiencing is serious or if you notice any adverse effect not mentioned in this leaflet, inform your doctor or pharmacist.

Contents of the leaflet:

  1. What is Peroxiben and what it is used for
  2. Before using Peroxiben
  3. How to use Peroxiben
  4. Possible side effects
  5. Storage of Peroxiben
  6. Additional information

1. What is PEROXIBEN and what it is used for

Benzoic peroxide, the active ingredient of this medication, has antimicrobial and sebostatic activity (regulating fat), and is capable of stopping the growth of Propionibacterium acne,the microorganism that causes acne.

Peroxiben is indicated for the local symptomatic treatment of moderate vulgar acne in adults and adolescents from 12 years old.

2. Before using PEROXIBEN

Do not use Peroxiben

  • If you are allergic (hypersensitive) to benzoic peroxide or to any of the other components of Peroxiben.

Be careful with Peroxiben

  • In case of very sensitive skin
  • This medication may cause skin irritation and some redness.

During the first application, you will probably notice mild burning, and some redness and skin peeling.

During the first weeks of treatment, skin peeling increases suddenly in most patients. Normally, it will decrease in one or two days if the treatment is temporarily interrupted. To prevent this effect, it is recommended to start the treatment in a small area, extending it to the affected area after a few days.

In case of mild irritation, applications should be spaced out.

If irritation persists or is intense, stop using Peroxiben, and carefully clean the skin with water and soap. If irritation continues after stopping the treatment, consult your doctor.

  • Do not use Peroxiben on damaged or eczematous skin, or on cuts or abrasions due to the possible risk of absorption. Avoid contact with the eyes, lips, mouth, nostrils, mucous membranes, or sensitive areas of the neck. In case of accidental contact, wash immediately with water.
  • The use of Peroxiben may cause discoloration of hair and certain dyed or colored tissues.

Use of other medications

Tell your doctor or pharmacist if you are using, or have recently used, other medications, including those purchased without a prescription.

Do not use Peroxiben with other medications or cosmetics that have peeling, irritating, and drying effects.

Peroxiben can be combined under medical supervision with other substances indicated for the treatment of seborrhea and acne.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using any medication.

Peroxiben should only be administered to pregnant women when a medical evaluation determines that the benefit outweighs the potential risk, as the safety of benzoic peroxide has not been established.

It is unknown whether Peroxiben is excreted in breast milk, so it should be administered with caution to breastfeeding women, and should not be applied to the breast to avoid transfer to the infant.

Driving and using machines

There is no indication that Peroxiben may affect the ability to drive or use machinery.

3. How to use PEROXIBEN

Adults and adolescents from 12 years old

After washing the affected area with water and soap, apply a small amount of Peroxiben to the same area with the fingertips, one or two times a day, depending on the intensity of the process and skin tolerance.

It is advisable to start treatment with Peroxiben 25 mg/g gel, switching to Peroxiben 50 mg/g gel or 100 mg/g gel after 3 or 4 weeks, or earlier in case of good tolerance to Peroxiben 25 mg/g gel.

Improvement can usually be observed after 4-6 weeks of treatment. However, longer use may be required.

Children under 12 years old

Do not use Peroxiben in children under 12 years old without medical supervision.

Consult your doctor or pharmacist if you have doubts.

If you use more PEROXIBEN than you should

If you have used more Peroxiben than you should, consult your doctor or pharmacist immediately. If you have used more Peroxiben than you should, your skin may become excessively red and painful. In this case, it should be applied more spaced out until this phase has passed. If irritation persists, consult your doctor.

In case of accidental ingestion, do not induce vomiting, rinse your mouth, and seek immediate medical attention.

In case of overdose or accidental ingestion, consult the Toxicology Information Service: Phone: 915 620 420.

If you forget to use PEROXIBEN

If you forget to administer a dose, apply the next one as soon as possible and continue administration as before. Do not administer a double dose to make up for forgotten doses.

4. Possible side effects

Like all medications, Peroxiben can cause side effects, although not all people experience them.

It is very common (in more than 1 in 10 patients) for the patient to feel a mild burning sensation with the first application, and for moderate redness, dryness, and skin peeling to appear after a few days. During the first weeks of treatment, a sudden increase in peeling, redness, itching, and pruritus (itching) may occur in most patients; this is not harmful and usually disappears in one or two days if the treatment is temporarily interrupted.

In rare cases (affecting 1 to 10 in 10,000 patients), allergic dermatitis may be observed.

During the authorization period of this medication, the following side effects have been observed, whose frequency could not be established with precision. The patient may experience temporary facial inflammation, dermatitis, or rash. In these cases, treatment should be interrupted immediately and a doctor consulted. These reactions are of unknown frequency and are usually reversible.

If you consider that any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.

5. Storage of PEROXIBEN

Keep out of the reach and sight of children.

Store below 30 °C.

Do not use Peroxiben after the expiration date shown on the packaging after the abbreviation "CAD". The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of packaging and medications that are no longer needed. This will help protect the environment.

6. Additional information

Composition of Peroxiben

The active ingredient is benzoic peroxide. Each gram of gel contains 50 mg of benzoic peroxide.

The other components are glycerol (E-422), aloe vera gel, carbomer, acrylic copolymer, simethicone, sodium hydroxide (E-524), disodium edetate, dioctyl sodium sulfosuccinate, and purified water.

Appearance of the product and packaging content

Peroxiben is presented in the form of a white gel, in a polyethylene tube with a polypropylene cap. Each tube contains 30 or 60 grams of gel.

Other presentations

Peroxiben 25 mg/g gel: tubes with 30 g of gel.

Peroxiben 100 mg/g gel: tubes with 30 or 60 g of gel.

Marketing authorization holder and manufacturer

Holder:

Isdin S.A.

Provençals 33

08019 Barcelona

Spain

Manufacturer:

Antonio Puig S.A.

C/ Berlín 12

Can Torella industrial estate

08233 Vacarisses (Barcelona)

Spain

This leaflet was revised:

June 2010

Alternatives to PEROXIBEN 50 mg/g GEL in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to PEROXIBEN 50 mg/g GEL in Poland

Dosage form: Gel, 50 mg/g
Active substance: benzoyl peroxide
Prescription not required
Dosage form: Gel, 100 mg/g
Active substance: benzoyl peroxide
Importer: Medinfar Manufacturing S.A.
Prescription not required
Dosage form: Gel, 50 mg/g
Active substance: benzoyl peroxide
Manufacturer: Almirall Hermal GmbH
Prescription not required
Dosage form: Gel, 100 mg/g
Active substance: benzoyl peroxide
Manufacturer: Almirall Hermal GmbH
Prescription not required

Alternative to PEROXIBEN 50 mg/g GEL in Ukraine

Dosage form: lotion, 10% in 30 ml bottle
Active substance: benzoyl peroxide
Manufacturer: Farmasajns Ink.
Prescription not required

Online doctors for PEROXIBEN 50 mg/g GEL

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for PEROXIBEN 50 mg/g GEL – subject to medical assessment and local rules.

5.0(2)
Doctor

Tomasz Grzelewski

Dermatology21 years of experience

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
CameraBook a video appointment
€80
Today11:00
Today11:25
Today11:50
Today12:15
Today12:40
More times
5.0(19)
Doctor

Anna Moret

Dermatology19 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for:

  • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis.
  • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis.
  • Pediatric skin problems — from newborns to adolescents.
  • Sexually transmitted infections (STIs) and dermatovenereology.
  • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments.
  • Skin allergies and hypersensitivity reactions.
  • Mole checks, lesion evaluation, and skin cancer screening.
  • Skincare advice and personalised cosmeceutical routines.

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

CameraBook a video appointment
€55
January 608:15
January 709:00
January 709:30
January 909:00
January 909:30
More times

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2026 Oladoctor. All rights reserved.
VisaMastercardStripe